Boltz vs PointClickCare

Side-by-side comparison of AI visibility scores, market position, and capabilities

PointClickCare leads in AI visibility (93 vs 21)
Boltz logo

Boltz

EmergingHealthcare Tech

AI Biomolecular Prediction

Open-source AI for biomolecular structure prediction. $28M seed from a16z. Pfizer collaboration. Boltz-2 rivals physics methods at 1000x speed. MIT spinout.

AI VisibilityBeta
Overall Score
D21
Category Rank
#1 of 1
AI Consensus
58%
Trend
up
Per Platform
ChatGPT
29
Perplexity
30
Gemini
17

About

Boltz was founded as a spinout from MIT with a mission to democratize access to AI-driven biomolecular structure prediction. The company was inspired by the transformative impact of AlphaFold on structural biology and sought to build the next generation of prediction systems that could go beyond protein structure to model the full complexity of biomolecular interactions, including protein-ligand binding, RNA folding, and multi-chain assemblies. By releasing its models as open source, Boltz made frontier-grade structural biology tools available to any researcher with a computer.\n\nBoltz-2, the company's latest model, rivals physics-based molecular dynamics simulations in accuracy while operating at approximately 1,000 times the speed, compressing computational experiments that once required weeks into hours or minutes. This performance profile makes Boltz-2 practical for drug discovery workflows where structural predictions must be generated across millions of candidate molecules. Boltz entered a collaboration with Pfizer, one of the world's largest pharmaceutical companies, to apply its models to drug discovery programs — a validation of both the technology's accuracy and its readiness for industrial-scale deployment.\n\nBoltz raised a $28 million seed round led by Andreessen Horowitz's bio fund, reflecting a16z's conviction that open-source biomolecular AI represents a foundational layer of the next generation of drug discovery infrastructure. The open-source strategy gives Boltz broad academic adoption and a rich pipeline of community feedback that accelerates model improvement. Its MIT lineage, Pfizer partnership, and a16z backing position Boltz as a leading independent AI platform in the computational biology space.

Full profile
PointClickCare logo

PointClickCare

LeaderSenior Care Tech

Long-Term Care Platform

Cloud-based EHR and care coordination platform for long-term and post-acute care organizations. Mississauga, Canada. Raised $172M+, unicorn. Serves 27,000+ care facilities across North America.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 1
AI Consensus
68%
Trend
up
Per Platform
ChatGPT
88
Perplexity
99
Gemini
99

About

PointClickCare is North America's leading cloud-based software platform for the long-term and post-acute care (LTPAC) market, headquartered in Mississauga, Ontario, Canada. Founded in 1999, the company has raised over $172 million and achieved unicorn valuation status. PointClickCare serves over 27,000 care facilities including skilled nursing facilities, senior living communities, assisted living centers, and home health agencies across the United States and Canada. The platform provides electronic health records (EHR), billing, care coordination, and business intelligence capabilities.\n\nPointClickCare's platform is built around the complex clinical and regulatory workflows unique to post-acute care, which differ substantially from acute hospital EHR requirements. The system manages MDS assessments, care planning, medication administration records, therapy documentation, and the complex billing requirements for Medicare, Medicaid, and managed care payers. Its network effect is significant — because PointClickCare connects so many facilities, care transitions between hospitals and post-acute settings can be managed with streamlined data exchange.\n\nThe company has expanded through strategic acquisitions including Collective Medical, which added care transition and high-risk patient identification capabilities powered by a large hospital and payer data network. PointClickCare's Marketplace ecosystem allows third-party technology vendors to integrate with the platform, creating an app store model that extends its functionality without requiring PointClickCare to build every adjacent capability. As value-based care models push accountable care organizations to manage patient outcomes across the full episode of care, PointClickCare's position at the post-acute node of the care continuum becomes increasingly strategically important.

Full profile

AI Visibility Head-to-Head

21
Overall Score
93
#1
Category Rank
#1
58
AI Consensus
68
up
Trend
up
29
ChatGPT
88
30
Perplexity
99
17
Gemini
99
20
Claude
99
15
Grok
91

Key Details

Category
AI Biomolecular Prediction
Long-Term Care Platform
Tier
Emerging
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Boltz
AI Biomolecular Prediction
Only PointClickCare
Long-Term Care Platform

Integrations

Only PointClickCare

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.